Rapid Ventricular Response Atrial Fibrillation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Rapid Ventricular Response Atrial Fibrillation trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT06376916

Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR

The purpose of this prospective, randomized, double-blinded study is to further evaluate the safety and efficacy of varying doses of intravenous magnesium in th…

United States153 participantsStarted 2024-10-07

Treatment: Magnesium Sulfate 2 G, Magnesium Sulfate 4 G

All recent trials (13 shown)

Not Yet RecruitingPhase 3

NCT06716021

ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

This is a multi-national, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of etripamil NS in patients with atrial fibri…

Location not specified750 participantsStarted 2027-01

Treatment: Placebo, Etripamil

CompletedPhase 4

NCT05661942

Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate

The purpose of this study is to see how well calcium pre-treatment works for decreasing incidence of drug-induced hypotension after diltiazem administration for…

United States92 participantsStarted 2022-11-30

Treatment: Calcium pre-treatment, Placebo

Rapid Ventricular Response Atrial Fibrillation

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR

All recent trials (13 shown)

ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR

All recent trials (13 shown)

ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate

Oral Bisoprolol Vs IV Diltiazem in Atrial Fibrillation or Flutter With Rapid Ventricular Rate.

Effectiveness of Repeated Amiodarone Dosing Regimen Versus Standard Dosing Regimen in Atrial Fibrillation Patient With R…

Role of IV Calcium to Prevent Diltiazem-related Hypotension

Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response

Assessment of Intravenous Rate Control Response in Atrial Fibrillation Trial (AIRCRAFT)

Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter

Control Versus Liberal Cardiac Frequency in Patients in Sepse With Atrial Fibrillation of High Ventricular Response

Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial Flutter

Rate Control in Atrial Fibrillation

Low Dose of Diltiazem for Rate Control of Atrial Fibrillation